⌘K

Home/Filings/4/0001209191-20-063097

4//SEC Filing

CHALMERS DEREK T 4

Accession 0001209191-20-063097

CIK 0001346830other

View on SEC.gov Company Profile

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 8:32 PM ET

Size

4.7 KB

Accession

0001209191-20-063097

Insider Transaction Report

Form 4

Period: 2020-12-10

Cara Therapeutics, Inc.CARA

CHALMERS DEREK T

DirectorPresident & CEO

Transactions

Sale
Common Stock
2020-12-10$15.29/sh−7,500$114,675→ 933,921 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cara Therapeutics, Inc.

CIK 0001346830

Entity typeother

Related Parties

1

filerCIK 0001166287

Filing Metadata

Form type: 4
Filed: Dec 10, 7:00 PM ET
Accepted: Dec 11, 8:32 PM ET
Size: 4.7 KB

View on SEC.gov